Fixed‐dose combination of amlodipine and atorvastatin improves clinical outcomes in patients with concomitant hypertension and dyslipidemia

Hypertension and dyslipidemia are important risk factors for cardiovascular disease. However, the clinical outcomes of fixed‐dose combination (FDC) versus free‐equivalent combination (FEC) of amlodipine and atorvastatin in the treatment of concurrent hypertension and dyslipidemia remain unknown. In...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :J Clin Hypertens (Greenwich)
Главные авторы: Lin, Chia‐Pin, Tung, Ying‐Chang, Hsiao, Fu‐Chih, Yang, Chia‐Hung, Kao, Yi‐Wei, Lin, Yu‐Sheng, Chu, You‐Chia, Chu, Pao‐Hsien
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley and Sons Inc. 2020
Предметы:
Combination Therapy
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8029959/
https://ncbi.nlm.nih.gov/pubmed/32862551
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jch.14016
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы